Jump to content
Powered by BIOPRO BW
  • BIOPRO BW
  • Healthcare industry
  • Project pages
    • MDR & IVDR
    • Innovation & Startups

Healthcare industry Logo

Main navigation

  • Start page Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close Close
  • Databases

    Databases

    Close Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Press release - 27/06/2025

    Felix Glang receives Otto Hahn Medal

    Felix Glang, of the Max Planck Institute for Biological Cybernetics in Tübingen, has been awarded the Otto Hahn Medal in recognition of his achievements in developing new magnetic resonance imaging (MRI) methods. Glang's methods enable clearer and faster brain scans.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/felix-glang-receives-otto-hahn-medal
  • Life-saving smartphone app delivers rapid help during cardiac arrest - 19/05/2025 A section of a three-dimensional city map shows the routes taken by the first responders to the scene of the emergency.

    Do smartphone-based first responder alerting systems increase the chances of survival in the event of cardiac arrest?

    Every minute counts when the heart suddenly stops beating or pumps so weakly that the brain is no longer receiving enough oxygen. The HEROES trial, coordinated in Freiburg, is investigating whether the survival rate of patients requiring out-of-hospital resuscitation improves when qualified first responders are alerted via the ‘Region of Lifesavers’ app - enabling them to begin high-quality resuscitation measures as early as possible.

    https://www.gesundheitsindustrie-bw.de/en/article/news/do-smartphone-based-first-responder-alerting-systems-increase-chances-survival-event-cardiac-arrest
  • Baden-Württemberg AI Alliance - 08/04/2025 There are two large computer screens on a desk with a computer mouse and keyboard. The screens show a stylized human head and a head in which parts of the brain structure are stylized. They are surrounded by a network.

    Achieving widespread use of AI

    Artificial intelligence presents both opportunities and risks. The Baden-Württemberg AI Alliance is dedicated to fostering collaboration among AI stakeholders to ensure that AI solutions deliver tangible benefits to citizens and businesses across the state. The alliance will also place greater emphasis on advancing AI applications within the healthcare sector.

    https://www.gesundheitsindustrie-bw.de/en/article/news/achieving-widespread-use-ai
  • Press release - 21/03/2025

    Risk-based assessment of AI in medicine

    A recent article by Prof. Dr. Martin Haimerl and Prof. Dr. Christoph Reich of Furtwangen University shows that machine learning (ML) in medicine is often evaluated without a comprehensive risk assessment. The authors investigated the extent to which current scientific papers include risk-based metrics in the evaluation of AI models for medical devices.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/risk-based-assessment-ai-medicine
  • Press release - 20/03/2025

    Start-up prize for "EmbryoNet AI Technologies"

    Using artificial intelligence to revolutionize drug development is the aim of the start-up "EmbryoNet AI Technologies" led by Konstanz biologist Patrick Müller. Müller and his team have now been awarded the start-up prize by the Federal Ministry for Economic Affairs and Climate Action (BMWK) for their business concept.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/start-prize-embryonet-ai-technologies
  • Press release - 11/03/2025

    Frequent blood donations promote the regeneration of blood cells through genetic adaptation

    Donating blood saves lives – but what long-term effects does this practice have on our bodies? Researchers from the German Cancer Research Center (DKFZ), the HI-STEM stem cell institute* and the German Red Cross Blood Donor Service, among others, have now discovered that frequent blood donations cause genetic adaptations in blood stem cells that promote the regeneration of blood cells.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/frequent-blood-donations-promote-regeneration-blood-cells-through-genetic-adaptation
  • New polymer for wound care - 09/01/2025 Das Bild zeigt einen Kühlakku, der gegen die Arminnenseite gehalten wird

    Thermoresponsive adhesive for pain-free removal of wound dressings

    Plasters or wound dressings can only perform their intended function if they adhere securely to the skin. However, they are often painful to remove, and in some cases, damage delicate newly formed tissue. Researchers at the University of Freiburg have developed an innovative polymer that adheres reliably at body temperature but can be easily and painlessly removed, leaving no residue, after being cooled.

    https://www.gesundheitsindustrie-bw.de/en/article/news/thermoresponsive-adhesive-pain-free-removal-wound-dressings
  • Vicinity Bio: Optimisation of cancer diagnostics - 27/11/2024 Das Bild zeigt eine mikroskopische Aufnahme eines Gewebes. Die Aufnahme ist bunt und unterschiedliche Zelltypen lassen sich deutlich erkennen.

    Comprehensive histological diagnostics through high-dimensional imaging and artificial intelligence

    Microscopic examination of tissue samples is essential, particularly in tumour diagnostics. The Tübingen-based company Vicinity Bio leverages cutting-edge imaging technologies combined with machine learning to generate comprehensive datasets of individual cells from tissue sections. This approach not only helps identify more targeted therapies but also enhances our understanding of cellular functions and processes within tissues and tumours.

    https://www.gesundheitsindustrie-bw.de/en/article/news/Comprehensive-histological-diagnostics-through-high-dimensional-imaging-and-artificial-intelligence
  • Greener NHS - 18/11/2024 Teaser image intended to represent the National Health Service in the UK. It shows the upper body of a doctor, with a hospital corridor in the background. To the right of the doctor is the slightly transparent outline of the British flag in the shape of Great Britain.

    National Health Service working towards climate neutrality

    The National Health Service (NHS) in the United Kingdom and Northern Ireland is taking steps to become more environmentally sustainable. The NHS has committed to the ambitious goal of achieving net zero carbon emissions by 2040, aiming to significantly reduce its climate impact in the coming years.

    https://www.gesundheitsindustrie-bw.de/en/article/news/national-health-service-working-towards-climate-neutrality
  • Press release - 15/11/2024

    Patient association raises 10,000 euros for work on PURA syndrome - Donation for research into rare neuronal developmental disorder at Ulm University

    PURA syndrome is a rare developmental disorder of the brain for which there is currently no cure. The patient association PURA Syndrome Germany was founded last year. Since then, the affected families have been collecting donations with great dedication – and have decided to donate the majority of this money to research into the syndrome at Ulm University.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/patient-association-raises-10000-euros-work-pura-syndrome-donation-research-rare-neuronal-developmental-disorder-ulm-university
  • NMI project WOUNDSENS - 23/10/2024 electrospinning_WoundSens.jpg

    Wound monitoring using sensory nanofibres

    Monitoring the condition of chronic, non-healing wounds requires wound dressings to be changed at short, regular intervals. In the EU-funded WOUNDSENS project, researchers at the NMI in Reutlingen are using electrospinning to produce novel types of wound dressings. These consist of biosensory fibres that send information about the condition of the wound to the outside, thereby improving inflammation detection.

    https://www.gesundheitsindustrie-bw.de/en/article/news/wound-monitoring-using-sensory-nanofibres
  • Sustainable medical technology - 10/10/2024 Various plastic medical items such as gloves, tablet blisters, containers, syringes and a blood pressure monitor are arranged on a green background.

    Rethinking plastics in medical technology

    Good healthcare relies heavily on medical products made from plastic. However, the widespread use of synthetic materials, particularly disposable items, creates vast amounts of waste, depletes resources and leads to a substantial carbon footprint. To create more environmentally friendly plastic products in the future, substantial changes to production processes are essential.

    https://www.gesundheitsindustrie-bw.de/en/article/news/rethinking-plastics-medical-technology
  • Press release - 09/10/2024

    Language model "UroBot“ surpasses the accuracy of experienced urologists

    Scientists at the German Cancer Research Center (DKFZ), together with doctors from the Urological Clinic of the Mannheim University Hospital, have developed and successfully tested a chatbot based on artificial intelligence. "UroBot" was able to answer questions from the urology specialist examination with a high degree of accuracy, surpassing both other language models and the accuracy of experienced urologists.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/language-model-urobot-surpasses-accuracy-experienced-urologists
  • Press release - 04/09/2024

    Epigenetic changes reprogram astrocytes into brain stem cells

    With mice, researchers showed that experimentally induced lack of blood flow in the brain epigenetically reprograms astrocytes into brain stem cells, which in turn can give rise to nerve progenitor cells. This discovery shows that astrocytes could potentially be used in regenerative medicine to replace damaged nerve cells.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/epigenetic-changes-reprogram-astrocytes-brain-stem-cells
  • Press release - 14/08/2024

    New vaccine against cervical cancer combines prophylactic and therapeutic activities

    Scientists at the German Cancer Research Center (DKFZ) have developed a completely new vaccination concept. The vaccine is inexpensive and protects mice against almost all cancer-causing HPV types. In addition to preventing new infections, the vaccine also triggers cellular immune responses against HPV-infected cells and may therefore also have a therapeutic effect against existing infections.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-vaccine-against-cervical-cancer-combines-prophylactic-and-therapeutic-activities
  • Start-up Cerebri GmbH - 05/08/2024 Cerebri-logo.png

    Comprehensive EEG supply thanks to telemedicine

    Fewer and fewer patients are getting timely access to electroencephalograms, as the process of measuring brain activity and interpreting the results requires specific expertise. Cerebri GmbH, a newly established Tübingen-based company, aims to address this issue by offering user-friendly EEG caps and providing rapid, location-independent and top-tier diagnostics by experts.

    https://www.gesundheitsindustrie-bw.de/en/article/news/comprehensive-eeg-supply-thanks-telemedicine
  • Research association - 24/07/2024 Graphic in which the various thematic lines of the performance centre are shown in a circle using symbols, e.g. the health thematic line as a heart with a graph of an ECG measurement.

    SPI-MP: pioneer in personalised medical technology

    Every person is unique – even when they are ill. This is why many approaches to personalised medicine have been under development. The Stuttgart Partnership Initiative - Mass Personalization (SPI-MP), which focuses on basic research into fabrication and biomaterial technologies for personalised biomedical systems, is at the heart of such research work. The projects range from artificial knee joint cartilage to state-of-the-art stroke diagnostics.

    https://www.gesundheitsindustrie-bw.de/en/article/news/spi-mp-pioneer-personalised-medical-technology
  • Press release - 02/07/2024

    Faster use of new technologies in rehabilitation

    BioRegio STERN Management GmbH is a partner in the new RehAllianCE project, which is being funded by the EU as part of the Interreg CENTRAL EUROPE program. The focus is on the use of new technologies in rehabilitation to improve patient care. The aim is to increase the innovation capacities of SMEs so that aids such as rehabilitation robots, exoskeletons etc. can be used more quickly.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/faster-use-new-technologies-rehabilitation
  • Press release - 24/06/2024

    Trustworthy AI Made in Mannheim

    How can we use artificial intelligence (AI) to make comprehensible medical decisions? A new project at the University of Mannheim, which has received funding from the Federal Ministry of Education and Research (BMBF), will analyze this question.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/trustworthy-ai-made-mannheim
  • Press release - 05/06/2024

    Investing in a fairer future: The Robert Bosch Stiftung celebrates its 60th anniversary

    he Robert Bosch Stiftung is celebrating its 60th anniversary in 2024. To commemorate this, the Foundation is holding an anniversary celebration today at its headquarters in Stuttgart. Among the guests are partners from the Foundation's charitable work as well as representatives from politics, business, and society, including members of the Bosch family and company.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/investing-fairer-future-robert-bosch-stiftung-celebrates-its-60th-anniversary
  • Press release - 24/05/2024

    Research Training Group on Cancer Surgery: German Research Foundation approves second funding period

    Since 2019, the Research Training Group (RTG) "Intraoperative Multisensoric Tissue Differentiation in Oncology," a collaboration between the University of Stuttgart and the University of Tübingen, has been advancing research in medical technology. With the help of new sensor methods, the researchers want to help make surgical procedures on cancer patients safer and more effective.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/research-training-group-cancer-surgery-german-research-foundation-approves-second-funding-period
  • Press release - 23/05/2024

    "They heal wounds, allow bones to grow and calm inflammation" MWK funds cell therapy research into mesenchymal stromal cells with 600,000 euros

    The Baden-Württemberg Ministry of Science, Research and Arts (MWK) is supporting medical researchers at Ulm University with start-up funding totalling 600,000 euros. The aim is to establish an EU consortium for the broad therapeutic use of mesenchymal stromal cells. The funding is being awarded as part of the "BEGIN - Participation in major European projects and initiatives" programme.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/they-heal-wounds-allow-bones-grow-and-calm-inflammation-mwk-funds-cell-therapy-research-mesenchymal-stromal-cells-600000-euros
  • Press release - 23/05/2024

    Predicting cancer risks on the basis of national health data

    Scientists from the German Cancer Research Center (DKFZ) and the European Bioinformatics Institute EMBL-EBI, Hinxton, UK, are using the Danish health registers to predict individual risks for 20 different types of cancer with a high degree of accuracy. The prediction model can also be transferred to other healthcare systems.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/predicting-cancer-risks-basis-national-health-data
  • Press release - 20/05/2024

    seleon GmbH becomes part of the aesco solutions group

    On May 17, 2024, aesco solutions, a leading group for production and development services (CDMO) for medical device companies, and D11Z. Ventures GmbH & Co. KG (formerly Zukunftsfonds Heilbronn) announce the closing of the acquisition of seleon GmbH.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/seleon-gmbh-becomes-part-aesco-solutions-group
  • Press release - 16/05/2024

    Colorectal cancer: tracking down subtypes

    Colorectal cancer differs from patient to patient. That is why scientists are looking for characteristic tumors markers that allow to make predictions about the likely response to certain therapies and the individual prognosis. The aim is to identify colorectal cancer subtypes so that these can then be treated in a customized manner.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/colorectal-cancer-tracking-down-subtypes
  • Press release - 15/05/2024

    Tumour tissue on a chip: new possibilities for cell therapies and personalized medicine

    How do tumors react to a certain therapeutic approach? Knowing this before the start of a therapy would be of enormous value for people suffering from cancer as well as for the doctors treating them. Researchers have now made this very observation possible for the CAR-T cell therapy. This allows us to individually investigate how exactly these tumor cells react to the planned therapy.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/tumour-tissue-chip-new-possibilities-cell-therapies-and-personalized-medicine
  • Press release - 13/05/2024

    Detecting respiratory infections: simply blow for diagnosis

    Professor Claudia Denkinger from Heidelberg University's Faculty of Medicine is leading the international collaborative project "BreathForDiagnosis". Researchers from Germany, Italy, South Africa and Romania are working with an industrial partner from Switzerland to develop user-friendly breath tests for the rapid diagnosis of respiratory infections such as tuberculosis.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/detecting-respiratory-infections-simply-blow-diagnosis
  • Press release - 07/05/2024

    Intermittent fasting protects against liver inflammation and liver cancer / Drug partially mimics fasting effects

    Fatty liver disease often leads to chronic liver inflammation and can even result in liver cancer. Scientists from the German Cancer Research Center (DKFZ) and the University of Tuebingen have now shown in mice that intermittent fasting can halt this development.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/intermittent-fasting-protects-against-liver-inflammation-and-liver-cancer-drug-partially-mimics-fasting-effects
  • Press release - 15/02/2024

    Modelling the spread of diseases

    Computer scientists from the Cluster of Excellence Collective Behaviour developed a model, that explains how collective scenarios such as diseases may proceed.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/modelling-spread-diseases
  • Health Data Futures project - 11/01/2024 Eine runde Darstellung der verschiedenen Szenario-Cluster, bei denen farblich markierten Szenarien in den Clustern herausgearbeitet wurden.

    Creating a network of trust

    In the three-nation project "Health Data Futures", stakeholders and experts from Germany, France and Switzerland have launched a series of patient-centred innovations. Using various future scenarios, the project partners may be able to come up with even more scenarios.

    https://www.gesundheitsindustrie-bw.de/en/article/news/creating-network-trust
  • Press release - 11/12/2023

    Heidelberg center for personalized medicine achieves the highest quality standards

    The German Cancer Society has certified the Center for Personalized Medicine (ZPM) at Heidelberg University Hospital. At the ZPM Heidelberg, patients with advanced and rare cancers and, in future, people with severe chronic inflammatory diseases will receive a molecular genetic analysis. The detailed information can open up new treatment options for those affected.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/zentrum-fuer-personalisierte-medizin-heidelberg-erfuellt-hoechste-qualitaetsstandards
  • Sustainability report - 31/08/2023 The 15 areas of healthcare are each represented by an icon and arranged in a circle around the ReKlimaMed logo.

    ReKlimaMed: how effective is the German healthcare sector when it comes to sustainability?

    Hospitals, care facilities and the healthcare industry, together with laboratories, private practices and pharmacies, ensure our medical care, but in so doing they produce enormous amounts of greenhouse gases and consume many resources. The ReKlimaMed report prepared by the viamedica foundation presents an inventory of current sustainable activities, and provides stakeholders with information and recommendations for action.

    https://www.gesundheitsindustrie-bw.de/en/article/news/reklimamed-how-effective-german-healthcare-sector-when-it-comes-sustainability
  • Press release - 18/08/2023

    TÜV SÜD gets UK Approved Body designation

    TÜV SÜD has received approval as a UK Approved Body (UKAB) for medical devices. With this approval, medical device manufacturers can implement UKCA certification for the UK market and CE certification for the European market in a time- and cost-efficient manner with TÜV SÜD.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/tuev-sued-gets-uk-approved-body-designation
  • Expert interview - 05/07/2023 Glove hand holding yellow container with plastic laboratory waste.

    Every tenth of a degree matters when it comes to mitigating the consequences of global warming: sustainability measures in the laboratory

    The life sciences sector consumes huge quantities of energy and resources. This needs to change and we have to think differently. But how and where can sustainability measures be sensibly applied in the laboratory without compromising the quality of research results? Dr. Kerstin Hermuth-Kleinschmidt, owner of NIUB-Nachhaltigkeitsberatung, a company from Freiburg that focuses on sustainability in life sciences, tells BIOPRO how this can be done.

    https://www.gesundheitsindustrie-bw.de/en/article/news/every-tenth-degree-matters-when-it-comes-mitigating-consequences-global-warming-sustainability-measures-laboratory
  • Press release - 16/06/2023

    What determines whether breast cancer cells can form metastases?

    In most cancers, it is not the growth of the primary tumor that determines the prognosis for the patient, but whether it will spread and form metastases. This process is very complex. There are often years between the development of the cancer and the aggressive growth of the metastases. Scientists from the DKFZ, the HI-STEM, the Ruhr University Bochum, Helmholtz Munich and ETH Zurich have studied and identified metastasis growth in breast cancer

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/what-determines-whether-breast-cancer-cells-can-form-metastases
  • Press release - 13/06/2023

    AutoProNano – international cooperation for in vitro and in vivo diagnostics

    The AutoProNano German/French collaborative project involves developing a process for the automated production of nanoparticles for in vitro and in vivo diagnostics. The project is being launched within the smart analytics cooperation network. This international initiative has been funded by the Central Innovation Programme for SMEs (ZIM) of the German Federal Ministry for Economic Affairs and Climate Action (BMWK) since May 2020.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/autopronano-international-cooperation-vitro-and-vivo-diagnostics
  • Press release - 25/05/2023

    Oops, did I do that – or is there someone else in my head?

    Tübingen researchers describe connection between action and feeling of authorship - finding sheds light on delusions of external control in schizophrenia

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/oops-did-i-do-or-there-someone-else-my-head
  • Value-based healthcare - 11/01/2023 Portrait photo of friendly smiling man with short gray hair and glasses wearing a suit.

    High-quality healthcare pays off

    High-quality medical treatment is not only worthwhile for ill persons. The Division of Health Economics at the German Cancer Research Center in Heidelberg, headed up by Prof. Dr. Michael Schlander, together with researchers from Dresden, has carried out a cost-effectiveness analysis that shows that certified colon cancer centres provide not only better but also more cost-effective care than other clinics.

    https://www.gesundheitsindustrie-bw.de/en/article/news/high-quality-healthcare-pays
  • Press release - 17/11/2022

    MEDICA and COMPAMED present themselves as extremely vital platforms in turbulent times

    MEDICA and COMPAMED continue to develop in an extremely vital manner. The world's leading medical trade fair and the international No. 1 for the medical technology supply sector once again impressively underscored their positive results from the previous year with strong numbers – despite continuing adverse conditions. A significant increase in bookings on the part of the exhibiting companies was followed after four days by a marked increase…

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/medica-und-compamed-praesentieren-sich-als-aeusserst-vitale-plattformen-bewegten-zeiten
  • Climate protection and sustainability in hospitals - 09/11/2022 Ellipsenförmig angeordnete schwarze, mit einem grünen Kreis hinterlegte Symbole für Klimaretter-Aktivitäten. Vorne ein Äskulapstab, seitlich ein Thermometer und Fahrrad und hinten ein Powerknopfzeichen und eine Heizung

    Sustainable activities in the healthcare sector

    The healthcare sector is not only facing major challenges in dealing with the consequences of climate change on human health, but it also needs to make a concrete contribution to reducing its own greenhouse gas emissions. Analyses show there are many opportunities to make medical care more sustainable, especially in hospitals’ daily routines. This is where the Heidelberg University Hospital and the viamedica foundation from Freiburg come in.

    https://www.gesundheitsindustrie-bw.de/en/article/news/sustainable-activities-healthcare-sector
  • Climate protection and sustainability in hospitals - 09/11/2022 Ellipsenförmig angeordnete schwarze, mit einem grünen Kreis hinterlegte Symbole für Klimaretter-Aktivitäten. Vorne ein Äskulapstab, seitlich ein Thermometer und Fahrrad und hinten ein Powerknopfzeichen und eine Heizung

    Sustainable activities in the healthcare sector

    The healthcare sector is not only facing major challenges in dealing with the consequences of climate change on human health, but it also needs to make a concrete contribution to reducing its own greenhouse gas emissions. Analyses show there are many opportunities to make medical care more sustainable, especially in hospitals’ daily routines. This is where the Heidelberg University Hospital and the viamedica foundation from Freiburg come in.

    https://www.gesundheitsindustrie-bw.de/en/article/news/sustainable-activities-healthcare-sector
  • Climate protection and sustainability in hospitals - 09/11/2022 Ellipsenförmig angeordnete schwarze, mit einem grünen Kreis hinterlegte Symbole für Klimaretter-Aktivitäten. Vorne ein Äskulapstab, seitlich ein Thermometer und Fahrrad und hinten ein Powerknopfzeichen und eine Heizung

    Sustainable activities in the healthcare sector

    The healthcare sector is not only facing major challenges in dealing with the consequences of climate change on human health, but it also needs to make a concrete contribution to reducing its own greenhouse gas emissions. Analyses show there are many opportunities to make medical care more sustainable, especially in hospitals’ daily routines. This is where the Heidelberg University Hospital and the viamedica foundation from Freiburg come in.

    https://www.gesundheitsindustrie-bw.de/en/article/news/sustainable-activities-healthcare-sector
  • Press release - 20/10/2022

    University of Tübingen and Boehringer Ingelheim Join Forces to Lead AI and Data Science R&D for New Medical Breakthroughs

    University of Tübingen, a leading member of Cyber Valley, Europe’s largest Artificial Intelligence (AI) research consortium and Boehringer Ingelheim launch an AI and data science fellowship program for top talents from around the world. Three to five fellowships will be awarded per year for up to three years with a target of nine to fifteen fellows in the program after five years.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/universitaet-tuebingen-und-boehringer-ingelheim-buendeln-kraefte
  • Dossier - 12/10/2022 Icon heart with ecg line on a green background

    The health sector must become greener

    Worldwide, the health sector is struggling with the consequences of global warming, but fatally is itself responsible for a significant proportion of greenhouse gas emissions. Studies show that hospitals and rehabilitation clinics in particular have great potential for reducing these emissions and, like the manufacturing industry, need to fundamentally revise established processes.

    https://www.gesundheitsindustrie-bw.de/en/article/dossier/health-sector-must-become-greener-1
  • Press release - 21/09/2022

    ERC funding: How to deliver gene therapies to a specific target site?

    With its "Proof of Concept" grants, the European Research Council ERC supports scientists in further developing the commercial potential of their research results. Nina Papavasiliou from the DKFZ is now receiving the prestigious grant for the second time: she wants to advance the development of a "molecular delivery service" that ensures that therapeutic genes reach the right address in the body in a targeted manner.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/erc-funding-how-deliver-gene-therapies-specific-target-site
  • Press release - 31/08/2022

    Using nanopores to detect epigenetic changes faster

    Changes known as epigenetic modifications play an important role in cancer development, among other things. Being able to analyze them quickly and reliably could, for example, contribute significantly to the further development of personalized therapy.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/using-nanopores-detect-epigenetic-changes-faster
  • Biotech in outer space - 06/07/2022 Scientist in the laboratory at a cell culture workbench with a cell chamber

    yuri, a space start-up: weightlessness for commercial research

    Growing cells without the effect of gravity could revolutionise drug development. A start-up called yuri on Lake Constance enables made-to-measure experiments on the ISS for stem cells, artificial organs, surfaces and materials. On board the next mission are some mini-cell labs from Berlin's Charité and Goethe University Frankfurt.

    https://www.gesundheitsindustrie-bw.de/en/article/news/yuri-space-start-weightlessness-commercial-research
  • Press release - 02/06/2022

    Groundbreaking ceremony for new research building on the Faculty of Engineering campus

    Dr. Nicole Hoffmeister-Kraut, Minister of Economic Affairs, Labour and Tourism of Baden-Württemberg, together with Freiburg’s Mayor Martin Horn, gives the go-ahead for the construction project on the Georges-Köhler-Allee.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/groundbreaking-ceremony-new-research-building-faculty-engineering-campus
  • Product testing under real conditions - 11/05/2022 The photo shows a modern hospital room with a nursing bed.

    INSPIRE Living Lab: a bridge between industry and the clinic

    Coming up with innovative ideas and products in the medical care area is highly relevant not only for the further development of Baden-Württemberg as a health region, but also for improving healthcare itself. However, bridging the gap between industry and the clinic often proves difficult. To drive this process forward, the INSPIRE Living Lab was opened at the University Medical Centre Mannheim in 2021.

    https://www.gesundheitsindustrie-bw.de/en/article/news/inspire-living-lab-bridge-between-industry-and-clinic
  • Press release - 01/03/2022

    CureVac Establishes Fully-Owned Company Dedicated to Advancing The RNA Printer®

    The RNA Printer® is CureVac’s integrated and automated manufacturing solution for RNA vaccines and therapeutics. CureVac RNA Printer GmbH to provide dedicated infrastructure to accelerate development and broaden application range of The RNA Printer®. Dr. Markus Bergmann appointed as General Manager for CureVac RNA Printer GmbH.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/curevac-gruendet-tochtergesellschaft-zur-weiterentwicklung-des-rna-printer
  • Press release - 03/02/2022

    The 5G-OR Project is a Winner of the joint Franco-German Program for the Development of innovative Applications for 5G private Networks

    5G-OR is one of the 4 winning projects jointly selected by the Federal Ministry of Economics and Climate Action in Germany and the Ministry of Economy, Finance and Relaunch in France for the call “Technical developments and application ecosystems for 5G private networks”. The joint Franco-German 5G-OR project takes up the challenge in the healthcare domain.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/5g-or-project-winner-joint-franco-german-program-development-innovative-applications-5g-private-networks
  • Press release - 14/12/2021

    EU regulation approved: G-BA collaborates on European health technology assessment

    Today, the EU Parliament adopted the EU Regulation on Health Technology Assessment (HTA), which includes not only new medicines (including gene and cell therapies), but also medical devices.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/eu-regulation-approved-g-ba-collaborates-european-health-technology-assessment
  • Funding

    EU4Health- Programme

    Funding programme, Funded by: European Union, sb_search.searchresult.label.programSubmissionDate: 31/12/2027
    https://www.gesundheitsindustrie-bw.de/en/database/funding/eu4health-programme
  • Expert interview - 31/08/2021 A coloured circular representation of different types of scenarios: 1a-c: Gradual evolution of the healthcare system, 2 a-b: Healthcare system change arises from cultural evolution, 3a-c: Healthcare system change arises from innovative technologies and cultural awareness change, 4a-b: Technology-driven healthcare system change.

    Health Data Scenarios - many possibilities for the future?

    The digitization of healthcare is progressing slowly but steadily. In addition to simple telemedical applications, data such as electronic patient records are forming the basis of digitization. The ‘Health Data Scenarios’ project aims to model the future of healthcare data by using scenarios. Lucas Scherdel, Healthcare Innovation Director at DayOne, and Dr. Alexander Fink, founder and CEO of ScMI AG, explain how this will work.

    https://www.gesundheitsindustrie-bw.de/en/article/news/health-data-scenarios-many-possibilities-future
  • Press release - 16/08/2021

    Heidelberg is calling for life sciences start-ups

    As a dominant part of southern Germany’s life-science industry hub, Heidelberg will soon have a life-science startup incubator of its own. BioLabs, the premier US network of managed co-working lab space, will open its first German branch in the Heidelberg Innovation Park (hip). On August 16, representatives of city and state governments, BioLabs and the life-science industry celebrated the Heidelberg BioLabs groundbreaking.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/heidelberg-calling-life-sciences-start-ups
  • Workplace of the future - 10/08/2021 Prototype image of a body support system that fixes a person at the abdomen and hips

    Intelligent body support system for surgery staff

    Operating room staff often spend hours in strenuous postures, which has a significant impact on concentration and quality of work. While operating room equipment is increasingly networked, state-of-the-art medical technology, conditions for operating room staff trail way behind. The start-up company Hellstern medical offers an effective solution for serious pain, fatigue and incorrect interventions.

    https://www.gesundheitsindustrie-bw.de/en/article/news/intelligent-body-support-system-surgery-staff
  • Expert interview - 03/03/2021 Screenshot_2021-02-10_at_15.57.101.png

    Healthcare movers – the future of Baden-Württemberg's healthcare industry

    The 'Healthcare Movers 2020 - Baden-Württemberg Report' reveals the potentials and challenges Baden-Württemberg healthcare companies encounter as the digital transformation of the healthcare market progresses. In an interview with Dr. Ariane Pott from BIOPRO, the authors of the report, Beatus Hofrichter and Dr. Ursula Kramer, explain what is required to take the major step towards becoming a digital avant-garde company.

    https://www.gesundheitsindustrie-bw.de/en/article/news/healthcare-movers-future-baden-wuerttembergs-healthcare-industry
  • Press release - 07/01/2021

    CureVac and Bayer join forces on COVID-19 vaccine candidate CVnCoV

    Bayer has signed a collaboration and services agreement with CureVac, a biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid. Under the terms of the agreement, Bayer will support the further development, supply and key territory operations of CureVac´s COVID-19 vaccine candidate CVnCoV.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/curevac-and-bayer-join-forces-covid-19-vaccine-candidate-cvncov
  • Innovative Therapies - 20/08/2020 Das Bild zeigt eine pipettierende Frau in Nahaufnahme. Symbolbild für analytische Dienstleistungen des portraitierten Unternehmens.

    Labor Dr. Merk is fully committed to viral therapies

    Labor Dr. Merk & Kollegen is reorienting its business towards viral therapeutics. With this change of strategy, the company, which has decades of expertise in virology, wants to position itself in a timely fashion in the growing new market for advanced therapy medicinal products (ATMP). In gene and virotherapies (oncolytic viruses), tumour vaccines and CAR-T cell therapies, viruses are essential as vectors, killers of tumour cells or…

    https://www.gesundheitsindustrie-bw.de/en/article/news/labor-dr-merk-fully-committed-viral-therapies
  • TGU Varimol - 24/07/2020 Das Bild zeigt zwei kleine braune Chemikalienfläschchen, die alle nötigen Reagenzien für ihre Anwendung für Kunden der Varimol enthalten.

    Click chemistry for new medical procedures

    Using a simple molecular click process, biochemists have been able to connect ring-shaped molecules with each other and couple therapeutically active substances to these molecules. Drugs can thus be specifically delivered to diseased cells and used for imaging processes or biosensors. The Stuttgart-based start-up Varimol is using this new technology to provide its customers with tailored applications that are as simple to use as a kit.

    https://www.gesundheitsindustrie-bw.de/en/article/news/click-chemistry-new-medical-procedures
  • Material research - 25/05/2020 Das Team der Yuri GmbH in Meckenbeuren

    Reaching up into weightlessness – a start-up that enables commercial research experiments in space

    Yuri, a start-up company founded in 2019 in the Lake Constance area, is aiming high. The company’s mission is to enable microgravity research into the development of materials, new medicines and vaccines, including research opportunities on the International Space Station (ISS). Yuri’s tailor-made solutions are faster and more affordable than previous space research missions.

    https://www.gesundheitsindustrie-bw.de/en/article/news/reaching-up-into-weightlessness-a-start-up-enables-commercial-research-experiments-in-space
  • Heidelberg Technology Park - 05/05/2020 Standort Im Neuenheim Feld des Technologieparks Heidelberg

    Start-up support for life sciences companies

    How can scientists turn their know-how into marketable products and services and thereby provide society with real added value? In addition to solid financing, start-up companies need a suitable infrastructure and a dense network of partners for exchanging expertise to help them get off to a good start when it comes to setting up a business. The Heidelberg Technology Park offers company founders in the life sciences exactly these success factors.

    https://www.gesundheitsindustrie-bw.de/en/article/news/start-up-support-for-life-sciences-companies
  • Article - 15/10/2019 Docdirekt_Bild_3.jpg

    docdirekt – a smart way to contact a doctor in Baden-Württemberg

    You feel unwell, but the family doctor’s practice is closed or it’s impossible to get an appointment at short notice. As part of their docdirekt project, the Baden-Württemberg Association of Statutory Health Insurance Physicians (in German: "Kassenärztliche Bundesvereinigung Baden-Württemberg (KVBW)) is now offering help for such cases. Everyone signed up to the statutory health insurance scheme will now be able to ring, contact via apps or…

    https://www.gesundheitsindustrie-bw.de/en/article/news/docdirekt-smart-zum-arzt-baden-wuerttemberg
  • Dossier - 09/09/2019 Close-up photo of robot with a human-like head, holding up a hand with fingers.

    Artificial intelligence in medicine: assistance for human senses

    There is no way around it. Whether we like it or not, artificial intelligence (AI) has long been part of our lives, in traffic management, marketing campaigns or in the fields of medicine and life sciences. AI is omnipresent, often without us being aware of it. Baden-Württemberg is home to one of the largest AI research consortia in Europe and has recently become one of the European hotspots for this key technology.

    https://www.gesundheitsindustrie-bw.de/en/article/dossier/artificial-intelligence-medicine-assistance-human-senses
  • Vision Zero in oncology - 02/09/2019 Titelcover_Vision-Zero.jpg

    Call for a comprehensive master plan for preventing and treating cancer

    While a cancer-free world may seem unrealistic given the increasing numbers of cancer cases, we need to reach a social consensus that cancer deaths are unacceptable and that everything possible must be done to prevent them. Leading cancer researchers around the world are calling for more investment in prevention research and cancer screening to move towards the vision of a near cancer-free world.

    https://www.gesundheitsindustrie-bw.de/en/article/news/call-for-comprehensive-master-plan-preventing-treating-cancer
  • New edition - 24/05/2019 Magnetic resonance image of brain metastases.

    Tumour metastasis

    Cancer is usually not curable when metastases have formed in the body. Metastases are often resistant to drugs that have successfully eliminated the primary tumour. The basic features of the complex process of metastasis are now known, but many details still remain elusive. Intensive research activities are focusing on new therapeutic concepts aimed at developing effective anti-metastatic therapies.

    https://www.gesundheitsindustrie-bw.de/en/article/dossier/tumour-metastasis
  • Expert interview - 13/05/2019 Telemedizin: Vitor Vieira (Inova DE) mit einem selbst entwickelten Wearable, einem T-Shirt zur verbesserten Interaktion zwischen Patienten und Kardiologen für fernkontrolliertes Monitoring

    Innovation management in the life sciences – Inova DE provides insights

    Personalized medicine, medical technology, digital health and artificial intelligence are revolutionizing diagnostics and product development. Analyses are becoming faster and more precise, and data volumes can now be networked and used effectively. The goal of improving people's quality of life is within reach, and this will also strengthen Germany’s future viability. However, not every good idea can be turned into a marketable commodity.…

    https://www.gesundheitsindustrie-bw.de/en/article/news/innovation-management-in-the-life-sciences-inova-de-provides-insights
  • Article - 23/04/2019 A picture of Martin Weweler

    How can care infrastructures benefit from digitization?

    The pilot project NeCTra (Networking - Care - Transparency) investigates how care processes within an urban social environment can be improved by using digital technologies. The goal is to bring together all partners and institutions in real time so that people in need of care and those seeking advice receive appropriate support more quickly.

    https://www.gesundheitsindustrie-bw.de/en/article/news/how-can-care-infrastructures-benefit-from-digitization
  • Article - 18/03/2019 European Union flag in the wind.

    EHR and PHR: digital records in the German healthcare system

    EHRs, i.e. electronic health records (German: Patientenakte, ePA), are hailed as the key to increasing the quality of care. The Appointment Service and Supply Act (TSVG), adopted on 14th March 2019, requires the German statutory health insurance funds to provide policyholders with electronic health records from 1st January 2021 onwards.

    https://www.gesundheitsindustrie-bw.de/en/article/news/ehr-and-phr-digital-records-in-the-german-healthcare-system
  • Article - 24/01/2019 The photo shows an ultra filtration system.

    Scientists to combat antibiotic-resistant bacteria in wastewater

    In Germany, around 1,500 tonnes of antibiotics per year are administered to humans and animals. As a result, more and more bacteria are developing resistance to common antibiotics. As part of HyReKA, a cooperative project funded by the BMBF, scientists led by Professor Thomas Schwartz from the KIT are investigating how antibiotic-resistant pathogens spread and how they can be prevented from doing so.

    https://www.gesundheitsindustrie-bw.de/en/article/news/scientists-to-combat-antibiotic-resistant-bacteria-in-wastewater
  • Expert interview - 16/01/2019 Photo of Holger Mettler

    Cybersecurity is an important issue for the pharmaceutical industry

    In an increasingly interconnected world, the pharmaceutical and biotechnology sectors need to be aware of cybersecurity threats in manufacturing. We talked about these threats with Holger Mettler who is in charge of computer system validation and cybersecurity at Exyte (formerly M + W), a global enterprise that designs, engineers and constructs complex manufacturing facilities and buildings for the life sciences industry.

    https://www.gesundheitsindustrie-bw.de/en/article/news/cybersecurity-is-an-important-issue-for-the-pharmaceutical-industry
  • Dossier - 28/08/2018 Woman wearing a white lab coat in a laboratory looking at a tube she is holding in her hand.

    With molecular diagnostics to biomarker-based personalised therapy

    Diagnosing suitable biomarkers is a prerequisite for tailoring personalised therapies to patient heterogeneity. Genetic tests and genome sequencing play a key role in these diagnoses. Up until now, personalised therapy has achieved the greatest success in the field of oncology. However, personalised treatments are also gaining in importance for treating other diseases.

    https://www.gesundheitsindustrie-bw.de/en/article/dossier/with-molecular-diagnostics-to-biomarker-based-personalised-therapy
  • High-tech - 20/10/2016 Man standing in front of a robot.

    Industry 4.0 in the medical technology and pharmaceutical industry sectors

    The digitalisation of industry affects the entire value chain. From individual products to digitising workflows in companies and connecting companies with clients and service providers via the Internet of Things – Industry 4.0 makes completely new manufacturing processes possible and requires new and specific business models.

    https://www.gesundheitsindustrie-bw.de/en/article/dossier/industry-40-in-the-medical-technology-and-pharmaceutical-industry-sectors
  • Overview

    BIOPRO services and offers

    https://www.gesundheitsindustrie-bw.de/en/biopro/services
  • Overview

    BIOPRO services

    https://www.gesundheitsindustrie-bw.de/en/biopro

Page 1 / 2

sb_search.block.search_result.other.pages

  • 1
  • 2
  • eine Seite zurück
  • Extend search to all portals
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • MDR & IVDR
    • Innovation & Startups
  • Portals
    • BIOPRO BW
    • Healthcare industry
  • To top

stay informed

Newsletter abonnieren

Social Media

  • Xing Xing
  • Twitter visit Twitter
  • LinkedIn visit LinkedIn
  • Rss visit RSS
  • Privacy statement
  • Accessability Declaration
  • Legal notice
  • Sitemap
  • Contact
© 2025
Website address: https://www.gesundheitsindustrie-bw.de/en/search